StocksFin Logo
HBIO logo
$HBIO

Harvard Bioscience, Inc.

HBIO country of incorporation
|
https://www.harvardbioscience.com
|
Mr. James Green
|
475 employees
NASDAQ | Healthcare | Medical Instruments & Supplies
HBIO reported its Q322 earnings on November 9, 2022 (103 weeks ago).
$26.92M -9.2% vs. Q321 Revenues Q322
45.21% -17.8% vs. Q321 Gross Profit Margin
-12.65% ! -2106.9% vs. Q321 Net Profit Margin
207k 118.2% vs. Q321 Free Cash Flow Q322
$-0.08 ! -1804.8% vs. Q321 EPS Q322
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
26.92M
-7.8%
14.75M
-3.41M
-239.8%
$-0.08
Q22022
29.21M
+1.5%
12.57M
2.44M
+135.4%
$0.06
Q12022
28.78M
12.6M
-6.88M
$-0.17
FY2021
33.06M
 13.5M
961k
$0.02
Q42021
33.06M
+11.4%
13.5M
961k
+665.3%
$0.02
Q32021
29.66M
+1.6%
13.36M
-170k
+58.5%
$-0
Q22021
29.2M
+8.2%
12.84M
-410k
+38.7%
$-0.01
Q12021
26.99M
11.56M
-669k
$-0.02
FY2020
102.1M
 44.06M
-7.81M
$-0.2
FY2019
116.18M
 51.85M
-4.69M
$-0.12
FY2018
120.77M
 57.59M
-2.92M
$-0.09
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
147.01M
 75.03M
5.14M
49.25M
71.98M
Q22022
155.27M
 77.77M
4.26M
56.4M
77.5M
Q12022
158.04M
 81.67M
5.43M
57.27M
76.38M
FY2021
162.34M
 70.41M
7.82M
55.85M
91.93M
FY2020
156.25M
 79.57M
8.32M
49.73M
76.68M
FY2019
164.87M
 83.18M
8.34M
60.72M
81.69M
FY2018
168.61M
 85.89M
8.17M
62.79M
82.72M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
649k
 -442k
377k
-442k
207k
+132.8%
Q22022
-190k
 -442k
-578k
-442k
-632k
+74.3%
Q12022
-1.99M
 -471k
94k
-471k
-2.46M
FY2021
1.26M
 -1.35M
-252k
-1.2M
67k
FY2020
9.33M
 -1.4M
-7.97M
-1.15M
8.18M
FY2019
8.05M
 -229k
-7.62M
-1.22M
6.83M
FY2018
2.88M
 -53.8M
53.05M
-1.01M
1.88M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees